Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
boston blog main
boston top stories
clinical trials
eli lilly
fda
life sciences
marc goodman
2
×
national blog main
national top stories
svb leerink
abbvie
alder biopharmaceutical
alkermes
american academy of neurology
amgen
atogepant
biohaven
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
buprenorphine
calcitonin gene-related peptide
cariprazine
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe
europe blog main
europe top stories
felipe jain
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
What
drug
2
×
fda
won
alkermes
antipsychotic
approval
arguments
benefits
big
caveats
class
commercialized
commonly
companies
competitors
decades
designed
drugs
effect
favor
gain
make
medicine
meeting
migraine
neuro
new
offer
oral
panel
potential
prescribed
psyche
therapies
treatment
vote
weighs
weight
year
Language
unset
Current search:
allergan
×
drug
×
" marc goodman "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
